207 related articles for article (PubMed ID: 25347453)
1. Antithrombotic therapy: new areas to understand efficacy and bleeding.
Wisler JW; Becker RC
Expert Opin Ther Targets; 2014 Dec; 18(12):1427-34. PubMed ID: 25347453
[TBL] [Abstract][Full Text] [Related]
2. Novel Antithrombotic Drugs on the Horizon: The Ultimate Promise to Prevent Clotting While Avoiding Bleeding.
McFadyen JD; Peter K
Circ Res; 2017 Oct; 121(10):1133-1135. PubMed ID: 29074533
[No Abstract] [Full Text] [Related]
3. Future Antithrombotic Therapies in Cardiology.
Bäuml M; Hilgendorf I
Hamostaseologie; 2018 Nov; 38(4):236-239. PubMed ID: 30267387
[TBL] [Abstract][Full Text] [Related]
4. Current antithrombotic agents for acute coronary syndromes: focus on bleeding risk.
Bassand JP
Int J Cardiol; 2013 Feb; 163(1):5-18. PubMed ID: 22100180
[TBL] [Abstract][Full Text] [Related]
5. The search for new antithrombotic mechanisms and therapies that may spare hemostasis.
Plow EF; Wang Y; Simon DI
Blood; 2018 Apr; 131(17):1899-1902. PubMed ID: 29467183
[TBL] [Abstract][Full Text] [Related]
6. From Patients to Platelets and Back Again: Pharmacological Approaches to Glycoprotein VI, a Thrilling Antithrombotic Target with Minor Bleeding Risks.
Martins Lima A; Martins Cavaco AC; Fraga-Silva RA; Eble JA; Stergiopulos N
Thromb Haemost; 2019 Nov; 119(11):1720-1739. PubMed ID: 31564053
[TBL] [Abstract][Full Text] [Related]
7. Blood coagulation: hemostasis and thrombin regulation.
Tanaka KA; Key NS; Levy JH
Anesth Analg; 2009 May; 108(5):1433-46. PubMed ID: 19372317
[TBL] [Abstract][Full Text] [Related]
8. Review: Nutriceuticals as antithrombotic agents.
Chakrabarti S; Freedman JE
Cardiovasc Ther; 2010 Aug; 28(4):227-35. PubMed ID: 20553290
[TBL] [Abstract][Full Text] [Related]
9. Current anticoagulant safety.
Denas G; Pengo V
Expert Opin Drug Saf; 2012 May; 11(3):401-13. PubMed ID: 22390628
[TBL] [Abstract][Full Text] [Related]
10. No risk, no benefit: still true for antithrombotic stroke treatments?
Minnerup J; Kleinschnitz C
Future Med Chem; 2013 Mar; 5(4):377-9. PubMed ID: 23495684
[No Abstract] [Full Text] [Related]
11. Impact of race and gender on antithrombotic therapy.
Capodanno D; Angiolillo DJ
Thromb Haemost; 2010 Sep; 104(3):471-84. PubMed ID: 20664898
[TBL] [Abstract][Full Text] [Related]
12. Thrombosis, antithrombotic agents, and the antithrombotic approach in cardiac disease.
Schussheim AE; Fuster V
Prog Cardiovasc Dis; 1997; 40(3):205-38. PubMed ID: 9406677
[TBL] [Abstract][Full Text] [Related]
13. [Hemostasis and blood coagulation revisited: mechanisms and therapeutic implications].
Hermans C; Deneys V
J Pharm Belg; 2004; 59(1):15-26. PubMed ID: 15129576
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of AR-H067637, the active metabolite of the new direct thrombin inhibitor AZD0837, in models of venous and arterial thrombosis and bleeding in anaesthetised rats.
Pehrsson S; Johansson K; Kjaer M; Elg M
Thromb Haemost; 2010 Dec; 104(6):1242-9. PubMed ID: 20806126
[TBL] [Abstract][Full Text] [Related]
15. Management of coagulation abnormalities in liver disease.
Potze W; Porte RJ; Lisman T
Expert Rev Gastroenterol Hepatol; 2015 Jan; 9(1):103-14. PubMed ID: 24970667
[TBL] [Abstract][Full Text] [Related]
16. Thrombosis: Novel target with antithrombotic potential and low bleeding risk.
Fernández-Ruiz I
Nat Rev Cardiol; 2017 Aug; 14(8):444. PubMed ID: 28631751
[No Abstract] [Full Text] [Related]
17. Antithrombotic agents and invasive procedures--hematologist point of view.
Lecompte TP
Thromb Res; 2012 Oct; 130 Suppl 1():S61-2. PubMed ID: 23026666
[TBL] [Abstract][Full Text] [Related]
18. Thrombosis and the pharmacology of antithrombotic agents.
Haines ST; Bussey HI
Ann Pharmacother; 1995 Sep; 29(9):892-905. PubMed ID: 8547739
[TBL] [Abstract][Full Text] [Related]
19. 2017 Scientific Sessions Sol Sherry Distinguished Lecture in Thrombosis: Factor XI as a Target for New Anticoagulants.
Weitz JI; Fredenburgh JC
Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):304-310. PubMed ID: 29269514
[TBL] [Abstract][Full Text] [Related]
20. A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis.
Vilahur G; Casaní L; Badimon L
Thromb Haemost; 2007 Sep; 98(3):662-9. PubMed ID: 17849057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
